TY - JOUR
T1 - Recurrent pericarditis
T2 - Infectious or autoimmune?
AU - Brucato, Antonio
AU - Maestroni, Silvia
AU - Cumetti, Davide
AU - Thiella, Giuseppe
AU - Alari, Gabriella
AU - Brambilla, Giovanni
AU - Imazio, Massimo
AU - Doria, Andrea
AU - Palmieri, Giancarlo
AU - Adler, Yehuda
PY - 2008/10
Y1 - 2008/10
N2 - The etiology and pathogenesis of idiopathic recurrent acute pericarditis (IRAP) remain controversial standing like a bridge that crosses infectious, autoimmune and autoinflammatory pathways. Anything may cause acute pericarditis; Echo-virus, and Coxsackie are the most frequently involved viruses, Mycobacterium tuberculosis and Coxiella burnetii the most common bacteria, but in 85% of cases it remains "idiopathic". Recurrences occur in up to 20-50% of patients. An immuno-mediated pathogenesis is suggested by the presence of pro-inflammatory cytokines in pericardial fluid, the presence of antinuclear autoantibodies (ANA) in sera of the patients, the occurrence of new autoimmune diagnoses and the good response to anti-inflammatory or immunosuppressive therapy. Nonsteroidal anti-inflammatory drugs (NSAIDs) must be used at recommended dosages, till the resolution of symptoms and normalization of C-reactive protein and erythrocyte sedimentation rate. Corticosteroids should be used rarely, at low doses, with an extremely low tapering and with osteoporosis prevention. Colchicine leads to a clinically important and statistically significant benefit, reducing recurrences by 50%. The long term outcome of IRAP is good, without evidence of constriction even after a very long follow-up.
AB - The etiology and pathogenesis of idiopathic recurrent acute pericarditis (IRAP) remain controversial standing like a bridge that crosses infectious, autoimmune and autoinflammatory pathways. Anything may cause acute pericarditis; Echo-virus, and Coxsackie are the most frequently involved viruses, Mycobacterium tuberculosis and Coxiella burnetii the most common bacteria, but in 85% of cases it remains "idiopathic". Recurrences occur in up to 20-50% of patients. An immuno-mediated pathogenesis is suggested by the presence of pro-inflammatory cytokines in pericardial fluid, the presence of antinuclear autoantibodies (ANA) in sera of the patients, the occurrence of new autoimmune diagnoses and the good response to anti-inflammatory or immunosuppressive therapy. Nonsteroidal anti-inflammatory drugs (NSAIDs) must be used at recommended dosages, till the resolution of symptoms and normalization of C-reactive protein and erythrocyte sedimentation rate. Corticosteroids should be used rarely, at low doses, with an extremely low tapering and with osteoporosis prevention. Colchicine leads to a clinically important and statistically significant benefit, reducing recurrences by 50%. The long term outcome of IRAP is good, without evidence of constriction even after a very long follow-up.
KW - Autoimmunity
KW - Long term outcomes
KW - Multidrug therapy
KW - Pericarditis
UR - http://www.scopus.com/inward/record.url?scp=54549123564&partnerID=8YFLogxK
U2 - 10.1016/j.autrev.2008.07.024
DO - 10.1016/j.autrev.2008.07.024
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 18708165
AN - SCOPUS:54549123564
SN - 1568-9972
VL - 8
SP - 44
EP - 47
JO - Autoimmunity Reviews
JF - Autoimmunity Reviews
IS - 1
ER -